期刊文献+

膝骨关节炎疼痛患者CRP和ESR变化的回顾调查 被引量:6

下载PDF
导出
摘要 目的目前骨科对于骨关节炎的诊断尚无明确的实验室诊断标准,但在实际临床工作中还需要一些实验室指标用以诊断和鉴别。本研究探讨骨科门诊主诉有骨关节炎疼痛患者的实验室检测指标C-反应蛋白和血沉的分布情况,为骨关节炎诊断提供前瞻性的辅助诊断,也同时为选择性COX-2抑制剂非甾体抗炎药的合理使用提供更明确的指针。方法随机抽取2010年10月~2012年12月骨科门诊主诉有膝关节疼痛患者1174名,空腹检测C-反应蛋白浓度和血沉;使用VAS评分评估膝关节疼痛程度。结果在1156例检测C-反应蛋白的患者中,CRP异常者占5.5%(64例),其中检测血沉的834例患者中,血沉异常者占23.14%(193例)。结论绝大部分主诉有膝关节疼痛的患者,其C-反应蛋白、血沉正常;但也有部分存在异常者,需要加以进一步诊断和鉴别。本研究提示C-反应蛋白、血沉可作为无菌性炎症的特异性指标,为骨关节炎的诊断及合理用药提供科学依据。
作者 蒋建新
出处 《继续医学教育》 2014年第6期29-32,共4页 Continuing Medical Education
  • 相关文献

参考文献19

  • 1Lisse J, Espinoza L, Zhao SZ, et al. Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib[J]. J Gerontol, 2001, 56(3): M167-M175.
  • 2Kang JD, Georgescu HI, Mclntyre-Larkin L, et al. Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2[J]. Spine,1995, 20(22): 2373-2378.
  • 3Zhao SZ, McMillen JI, Markenson JA, et al. Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib[J]. Pharmacotherapy, 1999, 19: 1269-1278.
  • 4Kivitz A J, Moskowitz RW, Woods E, et al. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip[J]. Int J Med Res, 2001,29: 467-479.
  • 5Plant M J, Williams AL, O'Sullivan MM, et al. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis[J]. Athritis & Rheumatism, 2000, 43(7): 1473-1477.
  • 6Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs[J]. Expert Opin Drug saf, 2009, 8(6): 669-681.
  • 7Attur M, Belitskaya-Lcvy I, Oh C, et al. Increased interleukin-113 gene expression in peripheral blood leukocytes is associated with increased pain andpredicts risk for progression of symptomatic knee osteoarthritis[J]. Athritis & Rheumatism, 2011, 63(7): 1908-1917.
  • 8McKenna F, Borenstein D, Wendt H, et al. Celecoxib versus diclofenac in the management of osteoarthritis of the knee[J] .Scand J Rheumatol, 2001,30: 11-18.
  • 9Suarez-Almazor ME. High burden of rheumatic disease in Mexico: a comprehensive community-based epidemiological study[J]. J Rheumatol, 2011, 1: 1-10.
  • 10Dnhlber LE, Holmel, Heye K, et al. Arandomized, muiticentre,double-blind, para Ilel-group study to assess the adverse event-related discontinuation rate with with celecoxib and diclfenac in elderly patients with osteoarthritis[J]. Scand J Rheumatol, 2009, 38(2): 133- 143.

同被引文献35

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部